Provided by Tiger Trade Technology Pte. Ltd.

Charles River Laboratories

273.41
+0.53000.19%
Volume:1.01M
Turnover:279.28M
Market Cap:13.05B
PE:-56.01
High:282.91
Open:272.78
Low:270.88
Close:272.88
52wk High:303.31
52wk Low:144.26
Shares:47.74M
Float Shares:47.20M
Volume Ratio:1.08
T/O Rate:2.15%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.8814
EPS(LYR):-2.9122
ROE:-7.52%
ROA:4.11%
PB:4.60
PE(LYR):-93.89

Loading ...

Charles River beats quarterly estimates on steady demand for drug development services

Reuters
·
May 07

GUIDANCE: (CRL) Charles River Laboratories International Expects 2026 Non-GAAP EPS Range $10.80 - $11.30, vs. FactSet Est of $11.08

MT Newswires Live
·
May 07

Charles River Q1 Adjusted EPS USD 2.06 Vs. IBES Estimate USD 1.94

Reuters
·
May 07

Charles River Q1 revenue and adjusted EPS beat estimates

Reuters
·
May 07

Charles River Q1 FY26 turns to net loss of $14.8 million; revenue rises 1.2% to $995.8 million

Reuters
·
May 07

Charles River Q1 Adj. EPS $2.06 Beats $1.94 Estimate, Sales $995.830M Beat $977.486M Estimate

Benzinga Earnings
·
May 07

Charles River Laboratories International Inc - Reaffirms 2026 Guidance for Organic Revenue and Non-Gaap Earnings per Share

THOMSON REUTERS
·
May 07

Charles River Outlook FY Revenue Growth -5.5 to -4%

THOMSON REUTERS
·
May 07

Charles River Laboratories International - Expects to Complete Sale of Certain European Discovery Services Sites in May 2026

THOMSON REUTERS
·
May 07

Press Release: Pharming Group reports first quarter 2026 financial results; on track for Joenja(R) U.S. pediatric label expansion and launches in Japan and Europe in 2026

Dow Jones
·
May 07

Charles River Laboratories International Inc. Stock Underperforms Wednesday When Compared To Competitors

Dow Jones
·
May 07

Charles River Laboratories International Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
May 05

Earning Preview: Charles River Laboratories this quarter’s revenue is expected to increase by 3.77%, and institutional views are broadly bullish

Earnings Agent
·
Apr 30

Charles River Laboratories International Inc. Stock Underperforms Wednesday When Compared To Competitors

Dow Jones
·
Apr 30

Charles River Laboratories International Inc. Stock Underperforms Tuesday When Compared To Competitors

Dow Jones
·
Apr 29

Charles River Laboratories International Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Apr 25

Charles River Laboratories International Inc. Stock Slides 9.2%, Underperforms Peers

Dow Jones
·
Apr 24

AbbVie receives CRL from FDA regarding BLA for trenibotulinumtoxinE

TIPRANKS
·
Apr 24

Grace Therapeutics Provides Regulatory Update on New Drug Application for GTx-104

GlobeNewswire
·
Apr 24

Revvity Falls 15.5%, Bio-Techne Drops 10.1%, IQVIA Drops 8.3%, Charles River Down 7%

THOMSON REUTERS
·
Apr 23